BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23214288)

  • 1. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

  • 6. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
    Feticu L; Bocşan IS; Bondor Cl; Boboş C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
    Wheeler CM
    Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M
    Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PAPILLOMAVIRUS INFECTION: PRINCIPLE CHARACTERISTICS, CLINICAL MANIFESTATIONS, VACCINE PROPHYLAXIS].
    Lopukhov PD; Briko NI; Khaldin AA; Tsapkova NN; Lupashko OV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):71-8. PubMed ID: 27029121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies against human papillomavirus infection and cervical cancer.
    Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
    J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How technology and vaccination have changed the Pap test].
    Bondi A; Ghidoni D; Amadori A
    Pathologica; 1999 Feb; 91(1):36-41. PubMed ID: 10396949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG; ter Harmsel WA; van Doorn LJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma viruses and cancer in the post-vaccine era.
    Galani E; Christodoulou C
    Clin Microbiol Infect; 2009 Nov; 15(11):977-81. PubMed ID: 19874381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomaviruses and cervical cancer.
    DiMaio D; Liao JB
    Adv Virus Res; 2006; 66():125-59. PubMed ID: 16877060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two HPV vaccines yielding similar success.
    Washam C
    J Natl Cancer Inst; 2005 Jul; 97(14):1030. PubMed ID: 16030297
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.